Tag: Abbott

Abbott gains US FDA approval for Proclaim Plus spinal cord stimulation...

Abbott has announced that the US Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360...

Updated medical policy expands patient access to Abbott’s DRG stimulation technology

Abbott announced today that UnitedHealthcare (UHC)—the largest private health insurance company in the USA—has updated its ‘Implanted electrical stimulator for spinal cord’ medical policy...

Proclaim XR spinal cord stimulation system gets expanded MRI compatibility boost

Abbott has announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR spinal cord...

Abbott launches NeuroSphere myPath digital health app 

Abbott has announced the launch of its NeuroSphere myPath digital health app, designed to track and report patient perceived pain relief and general well-being...

Spinal cord stimulation reduces or stabilises opioid use among chronic pain...

New research has found spinal cord stimulation therapy can reduce or stabilise the use of opioids in patients battling chronic pain. Researchers examined opioid...